Search

Search Constraints

You searched for: Date 2019 Author/Creator Hamamoto, Junko

Search Results

1. Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations. (January 2019)